Cancer statistics, 2010 - PubMed (original) (raw)
. 2010 Sep-Oct;60(5):277-300.
doi: 10.3322/caac.20073. Epub 2010 Jul 7.
Affiliations
- PMID: 20610543
- DOI: 10.3322/caac.20073
Free article
Cancer statistics, 2010
Ahmedin Jemal et al. CA Cancer J Clin. 2010 Sep-Oct.
Free article
Erratum in
- CA Cancer J Clin. 2011 Mar-Apr;61(2):133-4
Abstract
Each year, the American Cancer Society estimates the number of new cancer cases and deaths expected in the United States in the current year and compiles the most recent data regarding cancer incidence, mortality, and survival based on incidence data from the National Cancer Institute, the Centers for Disease Control and Prevention, and the North American Association of Central Cancer Registries and mortality data from the National Center for Health Statistics. Incidence and death rates are age-standardized to the 2000 US standard million population. A total of 1,529,560 new cancer cases and 569,490 deaths from cancer are projected to occur in the United States in 2010. Overall cancer incidence rates decreased in the most recent time period in both men (1.3% per year from 2000 to 2006) and women (0.5% per year from 1998 to 2006), largely due to decreases in the 3 major cancer sites in men (lung, prostate, and colon and rectum [colorectum]) and 2 major cancer sites in women (breast and colorectum). This decrease occurred in all racial/ethnic groups in both men and women with the exception of American Indian/Alaska Native women, in whom rates were stable. Among men, death rates for all races combined decreased by 21.0% between 1990 and 2006, with decreases in lung, prostate, and colorectal cancer rates accounting for nearly 80% of the total decrease. Among women, overall cancer death rates between 1991 and 2006 decreased by 12.3%, with decreases in breast and colorectal cancer rates accounting for 60% of the total decrease. The reduction in the overall cancer death rates translates to the avoidance of approximately 767,000 deaths from cancer over the 16-year period. This report also examines cancer incidence, mortality, and survival by site, sex, race/ethnicity, geographic area, and calendar year. Although progress has been made in reducing incidence and mortality rates and improving survival, cancer still accounts for more deaths than heart disease in persons younger than 85 years. Further progress can be accelerated by applying existing cancer control knowledge across all segments of the population and by supporting new discoveries in cancer prevention, early detection, and treatment.
Copyright 2010 American Cancer Society, Inc.
Similar articles
- Cancer statistics, 2009.
Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Jemal A, et al. CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49. doi: 10.3322/caac.20006. Epub 2009 May 27. CA Cancer J Clin. 2009. PMID: 19474385 - Cancer statistics, 2012.
Siegel R, Naishadham D, Jemal A. Siegel R, et al. CA Cancer J Clin. 2012 Jan-Feb;62(1):10-29. doi: 10.3322/caac.20138. Epub 2012 Jan 4. CA Cancer J Clin. 2012. PMID: 22237781 - Cancer statistics, 2007.
Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Jemal A, et al. CA Cancer J Clin. 2007 Jan-Feb;57(1):43-66. doi: 10.3322/canjclin.57.1.43. CA Cancer J Clin. 2007. PMID: 17237035 - Cancer statistics, 2004.
Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, Feuer EJ, Thun MJ; American Cancer Society. Jemal A, et al. CA Cancer J Clin. 2004 Jan-Feb;54(1):8-29. doi: 10.3322/canjclin.54.1.8. CA Cancer J Clin. 2004. PMID: 14974761 Review. - Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control.
Weir HK, Thun MJ, Hankey BF, Ries LA, Howe HL, Wingo PA, Jemal A, Ward E, Anderson RN, Edwards BK. Weir HK, et al. J Natl Cancer Inst. 2003 Sep 3;95(17):1276-99. doi: 10.1093/jnci/djg040. J Natl Cancer Inst. 2003. PMID: 12953083 Review.
Cited by
- Quantitative visually lossless compression ratio determination of JPEG2000 in digitized mammograms.
Georgiev VT, Karahaliou AN, Skiadopoulos SG, Arikidis NS, Kazantzi AD, Panayiotakis GS, Costaridou LI. Georgiev VT, et al. J Digit Imaging. 2013 Jun;26(3):427-39. doi: 10.1007/s10278-012-9538-7. J Digit Imaging. 2013. PMID: 23065144 Free PMC article. - Loss of FOXA1 Drives Sexually Dimorphic Changes in Urothelial Differentiation and Is an Independent Predictor of Poor Prognosis in Bladder Cancer.
Reddy OL, Cates JM, Gellert LL, Crist HS, Yang Z, Yamashita H, Taylor JA 3rd, Smith JA Jr, Chang SS, Cookson MS, You C, Barocas DA, Grabowska MM, Ye F, Wu XR, Yi Y, Matusik RJ, Kaestner KH, Clark PE, DeGraff DJ. Reddy OL, et al. Am J Pathol. 2015 May;185(5):1385-95. doi: 10.1016/j.ajpath.2015.01.014. Am J Pathol. 2015. PMID: 25907831 Free PMC article. - Trends in Adherence to Recommended Cancer Screening: The US Population and Working Cancer Survivors.
Clarke TC, Soler-Vila H, Fleming LE, Christ SL, Lee DJ, Arheart KL. Clarke TC, et al. Front Oncol. 2012 Dec 27;2:190. doi: 10.3389/fonc.2012.00190. eCollection 2012. Front Oncol. 2012. PMID: 23293767 Free PMC article. - βIII-tubulin overexpression is linked to aggressive tumor features and shortened survival in clear cell renal cell carcinoma.
Quaas A, Rahvar AH, Burdelski C, Koop C, Eichelberg C, Rink M, Dahlem R, Schlomm T, Tsourlakis MC, Simon R, Minner S, Sauter G, Steurer S. Quaas A, et al. World J Urol. 2015 Oct;33(10):1561-9. doi: 10.1007/s00345-014-1463-6. Epub 2014 Dec 21. World J Urol. 2015. PMID: 25527909 - Palliative radiation therapy practice in patients with metastatic non-small-cell lung cancer: a Cancer Care Outcomes Research and Surveillance Consortium (CanCORS) Study.
Chen AB, Cronin A, Weeks JC, Chrischilles EA, Malin J, Hayman JA, Schrag D. Chen AB, et al. J Clin Oncol. 2013 Feb 10;31(5):558-64. doi: 10.1200/jco.2012.43.7954. Epub 2013 Jan 7. J Clin Oncol. 2013. PMID: 23295799 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical